Looking at the whole industry, there are six characteristics in the production of pharmaceutical intermediates in China:
First,
most of the production enterprises are private enterprises with
flexible operation and small investment scale, basically between
millions and 120 million yuan;
Second, the geographical
distribution of production enterprises is relatively concentrated,
mainly in Taizhou, Zhejiang Province and Jintan, Jiangsu Province as the
center;
Third, with the increasing attention paid by the state
to environmental protection issues, the pressure on production
enterprises to build environmental protection treatment facilities has
increased;
Fourth, the product updates are fast. After a product
is generally marketed for 3-5 years, its profit margin drops
significantly, which forces enterprises to constantly develop new
products or improve production processes to maintain high production
profits;
Fifthly, because the production profit of pharmaceutical
intermediates is higher than that of chemical products, and the
production processes of the two are basically the same, more and more
small chemical enterprises have joined in the production of
pharmaceutical intermediates, leading to increasingly fierce disorderly
competition in the industry;
Sixth, compared with APIs, the
profit margin of intermediates is low, and the production process of
APIs and pharmaceutical intermediates is similar. Therefore, some
enterprises have not only produced intermediates, but also started to
produce APIs using their own advantages.